13F HOLDINGS REPORT
Samsara BioCapital, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061946
Total Value
$646.4M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SCHOLAR ROCK HLDG CORP | SRRK | 6,788,609 | $120.6M | 18.65% |
| 2 | CARGO THERAPEUTICS INC | 14179K101 | 4,121,689 | $92.0M | 14.23% |
| 3 | MINERALYS THERAPEUTICS INC | MLYS | 5,074,916 | $65.5M | 10.14% |
| 4 | NEUROGENE INC | NGNE | 1,267,790 | $64.5M | 9.98% |
| 5 | NKARTA INC | NKTX | 3,768,035 | $40.7M | 6.30% |
| 6 | ARCELLX INC | ACLX | 453,641 | $31.6M | 4.88% |
| 7 | LENZ THERAPEUTICS INC | LENZ | 1,208,473 | $27.0M | 4.17% |
| 8 | LYRA THERAPEUTICS INC | LYRA | 2,780,261 | $17.3M | 2.68% |
| 9 | ACELYRIN INC | 00445A100 | 2,523,022 | $17.0M | 2.63% |
| 10 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 967,527 | $16.3M | 2.53% |
| 11 | JASPER THERAPEUTICS INC | JSPRW | 525,000 | $15.4M | 2.38% |
| 12 | ZYMEWORKS INC | ZYME | 1,458,875 | $15.3M | 2.37% |
| 13 | HILLEVAX INC | 43157M102 | 799,274 | $13.3M | 2.06% |
| 14 | ABIVAX SA | AAVXF | 850,000 | $12.2M | 1.88% |
| 15 | INOZYME PHARMA INC | 45790W108 | 1,562,500 | $12.0M | 1.85% |
| 16 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,786,427 | $9.6M | 1.48% |
| 17 | SUTRO BIOPHARMA INC | STRO | 1,675,579 | $9.5M | 1.46% |
| 18 | RHYTHM PHARMACEUTICALS INC | RYTM | 172,647 | $7.5M | 1.16% |
| 19 | GOSSAMER BIO INC | GOSS | 6,130,268 | $7.2M | 1.12% |
| 20 | JANUX THERAPEUTICS INC | JANX | 180,207 | $6.8M | 1.05% |
| 21 | IO BIOTECH INC | IOBT | 3,640,015 | $6.3M | 0.97% |
| 22 | VERONA PHARMA PLC | 925050106 | 347,500 | $5.6M | 0.87% |
| 23 | TANGO THERAPEUTICS INC | TNGX | 630,000 | $5.0M | 0.77% |
| 24 | VTV THERAPEUTICS INC | VTVT | 206,784 | $4.9M | 0.75% |
| 25 | IMMATICS N.V | IMTX | 396,000 | $4.2M | 0.64% |
| 26 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 291,666 | $4.1M | 0.64% |
| 27 | PRIME MEDICINE INC | PRME | 540,304 | $3.8M | 0.59% |
| 28 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 196,425 | $3.2M | 0.50% |
| 29 | LEAP THERAPEUTICS INC | CYPH | 669,303 | $1.8M | 0.28% |
| 30 | IGM BIOSCIENCES INC | 449585108 | 154,664 | $1.5M | 0.23% |
| 31 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,049,153 | $1.5M | 0.23% |
| 32 | TERNS PHARMACEUTICALS INC | TERN | 202,348 | $1.3M | 0.21% |
| 33 | ACLARIS THERAPEUTICS INC | ACRS | 696,171 | $863,252 | 0.13% |
| 34 | VIRACTA THERAPEUTICS INC | 92765F108 | 689,709 | $703,503 | 0.11% |
| 35 | ALLAKOS INC | 01671P100 | 172,089 | $216,832 | 0.03% |
| 36 | KRONOS BIO INC | 50107A104 | 78,131 | $101,570 | 0.02% |
| 37 | ALLOVIR INC | 019818103 | 82,336 | $62,155 | 0.01% |
| 38 | NUVATION BIO INC | NUVB | 133,333 | $40,333 | 0.01% |
| 39 | SURROZEN INC | SRZNW | 99,999 | $3,020 | 0.00% |